API PartnershipThese are the types of agreements that will ensure they get financed. They now have proven they have the ability to create new drugs, this is significant. They are truely transforming themselves into a major player on the biotech scene. The other aspect is API is not for profit, therefore their drug development will be low cost compared to traditional programs. I do like the fact they are going to make new barium contrast, going to market in the US with new drugs will bring big value down the road. The new vanadium MRI drug is going to make this stock fly. A great partnership with an Edmonton based company that has all the labs and personel to go from pre-clinical through phased trials. Fantastic!!